The challenge of evaluating annual mammography screening for young women with a family history of breast cancer.

Fiona Jane Gilbert, The FH01 Management Committee, Steering Committee and Collaborators

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

It has been recommended that women aged 40-49 years with a significant family history of breast cancer should be offered annual mammography screening (http://www.nice.org.uk). An observational study known as FH01 (http: //www. screening services.org/btw/fh01/index.asp) is evaluating this policy in a cohort of 6000 women at moderately increased risk of breast cancer due to family history. The main aims are to assess the likely impact on breast cancer mortality and cost-effectiveness. Measuring these outcomes is challenging in an environment where a randomized trial is not feasible and there is no natural comparison group. In this paper, we present some approaches to estimating effectiveness and the planned analyses. These involve comparison of disease stage and likely consequent breast cancer mortality in the cohort offered screening with that estimated in the absence of screening. The estimation uses observed outcomes in external populations and estimated outcomes for the hypothetical situation where screening had not taken place.

Original languageEnglish
Pages (from-to)177-182
Number of pages5
JournalJournal of Medical Screening
Volume13
Publication statusPublished - 2006

Keywords

  • PROGRAM
  • RISK
  • POPULATION

Cite this

Gilbert, F. J., & The FH01 Management Committee, Steering Committee and Collaborators (2006). The challenge of evaluating annual mammography screening for young women with a family history of breast cancer. Journal of Medical Screening, 13, 177-182.

The challenge of evaluating annual mammography screening for young women with a family history of breast cancer. / Gilbert, Fiona Jane; The FH01 Management Committee, Steering Committee and Collaborators.

In: Journal of Medical Screening, Vol. 13, 2006, p. 177-182.

Research output: Contribution to journalArticle

Gilbert, FJ & The FH01 Management Committee, Steering Committee and Collaborators 2006, 'The challenge of evaluating annual mammography screening for young women with a family history of breast cancer.', Journal of Medical Screening, vol. 13, pp. 177-182.
Gilbert FJ, The FH01 Management Committee, Steering Committee and Collaborators. The challenge of evaluating annual mammography screening for young women with a family history of breast cancer. Journal of Medical Screening. 2006;13:177-182.
Gilbert, Fiona Jane ; The FH01 Management Committee, Steering Committee and Collaborators. / The challenge of evaluating annual mammography screening for young women with a family history of breast cancer. In: Journal of Medical Screening. 2006 ; Vol. 13. pp. 177-182.
@article{faab6d2ec2a84d7381668b48642cea71,
title = "The challenge of evaluating annual mammography screening for young women with a family history of breast cancer.",
abstract = "It has been recommended that women aged 40-49 years with a significant family history of breast cancer should be offered annual mammography screening (http://www.nice.org.uk). An observational study known as FH01 (http: //www. screening services.org/btw/fh01/index.asp) is evaluating this policy in a cohort of 6000 women at moderately increased risk of breast cancer due to family history. The main aims are to assess the likely impact on breast cancer mortality and cost-effectiveness. Measuring these outcomes is challenging in an environment where a randomized trial is not feasible and there is no natural comparison group. In this paper, we present some approaches to estimating effectiveness and the planned analyses. These involve comparison of disease stage and likely consequent breast cancer mortality in the cohort offered screening with that estimated in the absence of screening. The estimation uses observed outcomes in external populations and estimated outcomes for the hypothetical situation where screening had not taken place.",
keywords = "PROGRAM, RISK, POPULATION",
author = "Gilbert, {Fiona Jane} and {The FH01 Management Committee, Steering Committee and Collaborators}",
year = "2006",
language = "English",
volume = "13",
pages = "177--182",
journal = "Journal of Medical Screening",
issn = "0969-1413",
publisher = "SAGE Publications Ltd",

}

TY - JOUR

T1 - The challenge of evaluating annual mammography screening for young women with a family history of breast cancer.

AU - Gilbert, Fiona Jane

AU - The FH01 Management Committee, Steering Committee and Collaborators

PY - 2006

Y1 - 2006

N2 - It has been recommended that women aged 40-49 years with a significant family history of breast cancer should be offered annual mammography screening (http://www.nice.org.uk). An observational study known as FH01 (http: //www. screening services.org/btw/fh01/index.asp) is evaluating this policy in a cohort of 6000 women at moderately increased risk of breast cancer due to family history. The main aims are to assess the likely impact on breast cancer mortality and cost-effectiveness. Measuring these outcomes is challenging in an environment where a randomized trial is not feasible and there is no natural comparison group. In this paper, we present some approaches to estimating effectiveness and the planned analyses. These involve comparison of disease stage and likely consequent breast cancer mortality in the cohort offered screening with that estimated in the absence of screening. The estimation uses observed outcomes in external populations and estimated outcomes for the hypothetical situation where screening had not taken place.

AB - It has been recommended that women aged 40-49 years with a significant family history of breast cancer should be offered annual mammography screening (http://www.nice.org.uk). An observational study known as FH01 (http: //www. screening services.org/btw/fh01/index.asp) is evaluating this policy in a cohort of 6000 women at moderately increased risk of breast cancer due to family history. The main aims are to assess the likely impact on breast cancer mortality and cost-effectiveness. Measuring these outcomes is challenging in an environment where a randomized trial is not feasible and there is no natural comparison group. In this paper, we present some approaches to estimating effectiveness and the planned analyses. These involve comparison of disease stage and likely consequent breast cancer mortality in the cohort offered screening with that estimated in the absence of screening. The estimation uses observed outcomes in external populations and estimated outcomes for the hypothetical situation where screening had not taken place.

KW - PROGRAM

KW - RISK

KW - POPULATION

M3 - Article

VL - 13

SP - 177

EP - 182

JO - Journal of Medical Screening

JF - Journal of Medical Screening

SN - 0969-1413

ER -